Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (131-140 of 412) with videos related to

Pageof 42
Sort By:
Cancer Research|December 3, 2004
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanomaKyle A Divito, Aaron J Berger, Robert L Camp, et al.
Breast Cancer Research : BCR|September 3, 2010
Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic modelsFabio Parisi, Ana M Gonzalez, Yasmine Nadler, et al.
Breast Cancer Research : BCR|April 24, 2008
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancerYasmine Nadler, Robert L Camp, Jennifer M Giltnane, et al.
Journal for Immunotherapy of Cancer|July 25, 2019
Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanomaPok Fai Wong, Wei Wei, Swati Gupta, et al.
Human Pathology|September 19, 2008
Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancerC A W Sullivan, S Ghosh, I T Ocal, et al.
Archives of Pathology & Laboratory Medicine|October 7, 2008
Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancerJennifer M Giltnane, Annette Molinaro, Huan Cheng, et al.
Cancer|September 5, 2002
Immunocytochemical analysis of breast cells obtained by ductal lavageBonnie L King, Giovanna M Crisi, Steven C Tsai, et al.
International Journal of Cancer|December 21, 2002
Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcomeEric Kielhorn, Elayne Provost, Drew Olsen, et al.
Melanoma Research|June 5, 2004
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray studyHarriet M Kluger, Kyle DiVito, Aaron J Berger, et al.
Nature Reviews. Clinical Oncology|January 17, 2025
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approachMiguel Lopez de Rodas, Maria Villalba-Esparza, Miguel F Sanmamed, et al.
Pageof 42

Showing results (131-140 of 412) with videos related to

Sort By:
Pageof 42
Cancer Research|December 3, 2004
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanomaKyle A Divito, Aaron J Berger, Robert L Camp, et al.
Breast Cancer Research : BCR|September 3, 2010
Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic modelsFabio Parisi, Ana M Gonzalez, Yasmine Nadler, et al.
Breast Cancer Research : BCR|April 24, 2008
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancerYasmine Nadler, Robert L Camp, Jennifer M Giltnane, et al.
Journal for Immunotherapy of Cancer|July 25, 2019
Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanomaPok Fai Wong, Wei Wei, Swati Gupta, et al.
Human Pathology|September 19, 2008
Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancerC A W Sullivan, S Ghosh, I T Ocal, et al.
Archives of Pathology & Laboratory Medicine|October 7, 2008
Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancerJennifer M Giltnane, Annette Molinaro, Huan Cheng, et al.
Cancer|September 5, 2002
Immunocytochemical analysis of breast cells obtained by ductal lavageBonnie L King, Giovanna M Crisi, Steven C Tsai, et al.
International Journal of Cancer|December 21, 2002
Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcomeEric Kielhorn, Elayne Provost, Drew Olsen, et al.
Melanoma Research|June 5, 2004
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray studyHarriet M Kluger, Kyle DiVito, Aaron J Berger, et al.
Nature Reviews. Clinical Oncology|January 17, 2025
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approachMiguel Lopez de Rodas, Maria Villalba-Esparza, Miguel F Sanmamed, et al.
Pageof 42